Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia

Key Points

• Childhood maltreatment correlates with worse treatment responses in schizophrenia, indicating a need for tailored approaches.
• In trials assessing pharmacotherapy, adverse childhood experiences significantly influence symptom management, highlighting an often-overlooked factor.
• Analysis of multiple pharmacotherapy trials shows childhood adversity as a critical variable affecting treatment efficacy and patient outcomes.
• Understanding how childhood maltreatment interacts with pharmacotherapy could inform clinical strategies and improve patient care.